Impact of National Drug Price Negotiation Policy for Medical Insurance on the cost-effectiveness of budesonide, glycopyrronium bromide/formoterol for moderate to very severe chronic obstructive pulmonary disease

Pengpeng WANG, Le LIANG, Yamei LI

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (3) : 54-61.

PDF(1170 KB)
Welcome to visit Clinical Medication Journal!
PDF(1170 KB)
Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (3) : 54-61. DOI: 10.3969/j.issn.1672-3384.2025.03.009
Original Article

Impact of National Drug Price Negotiation Policy for Medical Insurance on the cost-effectiveness of budesonide, glycopyrronium bromide/formoterol for moderate to very severe chronic obstructive pulmonary disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(3): 54-61 https://doi.org/10.3969/j.issn.1672-3384.2025.03.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1170 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Clinical Medication Journal, All Rights Reserved.
Tel: 010-64178704转301/302/305/306　
E-mail：zazhi@vip.sina.com
Powered by Beijing Magtech Co. Ltd.

/

〈 〉